OMNI
company
About
OMNI is a pharmaceutical company that focuses on drug delivery technologies.
- 251 - 500
Highlights
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- ¥20M
- Industries
- Biotechnology,Health Care,Medical Device,Pharmaceutical
- Founded date
- Jan 1, 2011
- Number Of Employee
- 251 - 500
- Operating Status
- Active
Funding Rounds
Number of Funding Rounds
Total Funding Amount
4
¥33M
OMNI has raised a total of
¥33M
in funding over 2 rounds. Their latest funding was raised on
Dec 27, 2021 from a Series D round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 27, 2021 | Series D | — | 1 | — | — | Detail |
| Sep 29, 2017 | Series B | ¥20M | 2 | — | — | Detail |
| Sep 22, 2015 | Series A | ¥10M | 2 | — | — | Detail |
| Feb 19, 2013 | Angel | ¥3M | 1 |
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
6
OMNI is funded by 6 investors.
Haimen Pushi Yiyao
and Zhangkelingyi
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Angel |
|
|
— | Series D |
|
|
— | Series B |
|
|
— | Series B |
|
|
— | Series A |
|
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
